The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $71.65

Today's change+0.36 +0.50%
Updated March 23 3:21 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $71.65

Today's change+0.36 +0.50%
Updated March 23 3:21 PM EDT. Delayed by at least 15 minutes.

ResMed Inc crosses above 20-day moving average

ResMed Inc is up today by (U.S.)$0.36 or 0.50% to (U.S.)$71.65 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.52% and are currently 2.46% off of the 52-week high. Shares have outperformed the S&P 500 by 11.81% during the last year.

Key company metrics

  • Open(U.S.) $71.18
  • Previous close(U.S.) $71.29
  • High(U.S.) $72.09
  • Low(U.S.) $71.04
  • Bid / Ask(U.S.) $71.63 / (U.S.) $71.69
  • YTD % change+15.47%
  • Volume422,680
  • Average volume (10-day)546,751
  • Average volume (1-month)623,619
  • Average volume (3-month)814,818
  • 52-week range(U.S.) $55.13 to (U.S.) $73.46
  • Beta0.86
  • Trailing P/E30.38×
  • P/E 1 year forward25.25×
  • Forward PEG2.47×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.84%
  • Trailing EPS(U.S.) $2.36
Updated March 23 3:21 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.65%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue530465519454
Total other revenue--------
Total revenue530465519454
Gross profit309269301260
Total cost of revenue221196217194
Total operating expense434371400350
Selling / general / administrative139129136123
Research & development38343428
Depreciation / amortization1212135
Interest expense (income), net operating--------
Unusual expense (income)23--00
Other operating expenses, total--------
Operating income9794119104
Interest income (expense), net non-operating-----11--
Gain (loss) on sale of assets--------
Other--------
Income before tax9693117109
Income after tax77769388
Income tax, total19172421
Net income77769388
Total adjustments to net income--------
Net income before extra. items77769388
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items77769388
Inc. avail. to common incl. extra. items77769388
Diluted net income77769388
Dilution adjustment--00--
Diluted weighted average shares142142142141
Diluted EPS excluding extraordinary itemsvalue per share0.540.540.660.63
Dividends per sharevalue per share0.330.330.300.30
Diluted normalized EPSvalue per share0.670.540.660.63